Market Closed -
Nasdaq Stockholm
05:01:19 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
69.6
SEK
|
+1.16%
|
|
+0.87%
|
+12.62%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,869
|
2,166
|
2,439
|
-
|
-
|
Enterprise Value (EV)
1 |
3,869
|
2,276
|
2,621
|
2,618
|
2,576
|
P/E ratio
|
-73.1
x
|
-15.6
x
|
-30.6
x
|
-84.9
x
|
58.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
9.7
x
|
11.5
x
|
10.3
x
|
8.05
x
|
EV / Revenue
|
-
|
10.2
x
|
12.4
x
|
11.1
x
|
8.5
x
|
EV / EBITDA
|
-
|
-29.9
x
|
-165
x
|
76.5
x
|
31.4
x
|
EV / FCF
|
-
|
-
|
-32.8
x
|
-374
x
|
80.5
x
|
FCF Yield
|
-
|
-
|
-3.05%
|
-0.27%
|
1.24%
|
Price to Book
|
-
|
-
|
8.8
x
|
9.81
x
|
8.39
x
|
Nbr of stocks (in thousands)
|
35,044
|
35,044
|
35,044
|
-
|
-
|
Reference price
2 |
110.4
|
61.80
|
68.80
|
68.80
|
68.80
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
223.2
|
211.8
|
236.8
|
303
|
EBITDA
1 |
-
|
-76.07
|
-15.93
|
34.22
|
82
|
EBIT
1 |
-
|
-131.9
|
-65.06
|
-13.98
|
57
|
Operating Margin
|
-
|
-59.12%
|
-30.73%
|
-5.9%
|
18.81%
|
Earnings before Tax (EBT)
1 |
-
|
-147.2
|
-83.06
|
-29.98
|
44
|
Net income
1 |
-52.88
|
-138.4
|
-78.98
|
-28.22
|
41
|
Net margin
|
-
|
-62.01%
|
-37.3%
|
-11.92%
|
13.53%
|
EPS
2 |
-1.510
|
-3.950
|
-2.250
|
-0.8100
|
1.180
|
Free Cash Flow
1 |
-
|
-
|
-80
|
-7
|
32
|
FCF margin
|
-
|
-
|
-37.78%
|
-2.96%
|
10.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
39.02%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
78.05%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
58.79
|
53
|
53
|
55
|
EBITDA
1 |
-1.501
|
-6
|
-3
|
1
|
EBIT
1 |
-12.87
|
-18
|
-16
|
-11
|
Operating Margin
|
-21.89%
|
-33.96%
|
-30.19%
|
-20%
|
Earnings before Tax (EBT)
1 |
-12.2
|
-22
|
-20
|
-16
|
Net income
1 |
-9.901
|
-21
|
-19
|
-15
|
Net margin
|
-16.84%
|
-39.62%
|
-35.85%
|
-27.27%
|
EPS
2 |
-0.2800
|
-0.6100
|
-0.5400
|
-0.4300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
110
|
182
|
179
|
137
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-1.445
x
|
-11.43
x
|
5.229
x
|
1.671
x
|
Free Cash Flow
1 |
-
|
-
|
-80
|
-7
|
32
|
ROE (net income / shareholders' equity)
|
-
|
-32.6%
|
-25.2%
|
-10.9%
|
15.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
7.820
|
7.010
|
8.200
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
7.19
|
7
|
10
|
12
|
Capex / Sales
|
-
|
3.22%
|
3.31%
|
4.22%
|
3.96%
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +12.62% | 220M | | +11.63% | 27.79B | | -31.67% | 2.98B | | -14.68% | 2.52B | | +11.64% | 2.34B | | +2.96% | 1.91B | | -11.65% | 1.83B | | -1.67% | 1.39B | | -0.38% | 1.27B | | +3.58% | 1.13B |
Medical Supplies
|